InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Hansen Carl L. G., Chairman & CEO. Officer active across 1 company, notably AbCellera Biologics Inc.. Aggregated, 14 filings have been published. Split: 0 buy · 1 sell. Total volume traded: €110.4m. History available since 9 June 2021. The latest transaction was disclosed on 25 November 2024 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Hansen Carl L. G.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations14 total
56,125 shares@ US$2.700.1% of flowCommon SharesSEC:0001628280-24-049327:0
56,125 shares@ US$2.700.1% of flowCommon SharesSEC:0001628280-24-041217:0
56,125 shares@ US$2.700.1% of flowCommon SharesSEC:0001628280-24-026338:0
56,125 shares@ US$2.700.1% of flowCommon SharesSEC:0001703057-24-000026:0
56,125 shares@ US$2.700.1% of flowCommon SharesSEC:0001703057-23-000044:0
56,125 shares@ US$2.700.1% of flowCommon SharesSEC:0001703057-23-000027:0
56,125 shares@ US$2.700.1% of flowCommon SharesSEC:0001209191-23-032793:0
56,125 shares@ US$2.700.1% of flowCommon SharesSEC:0001209191-23-012199:0
56,125 shares@ US$2.700.1% of flowCommon SharesSEC:0001209191-22-058300:0
56,125 shares@ US$2.700.1% of flowCommon SharesSEC:0001209191-22-046995:0
56,125 shares@ US$2.700.012% mcap0.1% of flowCommon SharesSEC:0001209191-22-030394:0
56,125 shares@ US$2.700.1% of flowCommon SharesSEC:0001209191-22-013012:0
224,500 shares@ US$15.032.6% of flowCommon SharesSEC:0001209191-21-066133:0
5,598,420 shares@ US$24.0395.9% of flowCommon SharesSEC:0000899243-21-022993:0
14 of 14 declarations
About Hansen Carl L. G.
Hansen Carl L. G. is Président-Directeur Général and Chief Executive Officer at AbCellera Biologics Inc. His 14 filings concern AbCellera Biologics Inc. and, for the 14 sampled filings, they cover the period from 2021-06-10 to 2024-11-26, with buys of EUR 0 and sells of EUR 110433413. The most frequent transaction nature is Levée d'options.
